Rosie Kizza, Ph.D, MHSA, BSN
Clinical Research Coordinator III
On This Page
About Rosie Kizza
As a clinical research coordinator III, Rosie is responsible for providing support with regulatory submission management of investigator-initiated and industry-sponsored protocols, the implementation of standard operating procedures, direct patient care in clinical trials, and collaboration with the clinical research staff.
Publications
Academic Articles
-
How is your biobank handling disaster recovery efforts?
- Journal
- Biopreservation and biobanking.
- Volume/Issue
- 11(4):194-201
- [DOI]
- 10.1089/bio.2013.1142.
- [PMID]
- 24845584.
Grants
-
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Active
- Role:
- Other
- Funding:
- UNITED THERAPEUTICS CORP
-
A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
- Role:
- Other
- Funding:
- BOEHRINGER INGELHEIM PHARM INC
-
A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF)
- Role:
- Other
- Funding:
- BOEHRINGER INGELHEIM PHARM INC
-
A Randomized, Double-blind, Placebo-controlled Phase 2 Study with Open-label Extension to Assess the Efficacy and Safety of Namilumab in Subjects with Chronic Pulmonary Sarcoidosis.
- Role:
- Other
- Funding:
- KINEVANT SCIENCES
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Pulmonary Fibrosis
- Role:
- Other
- Funding:
- BRISTOL MYERS SQUIBB CO
Contact Details
- Business:
- (352) 273-6575
- Business:
- rosie.kizza@medicine.ufl.edu
- Business Mailing:
-
PO Box 100254
GAINESVILLE FL 32610 - Business Street:
-
1329 SW 16TH ST STE 4280
GAINESVILLE FL 32608